Samsung Biologics Labor Talks Continue Ahead Of September Mediation - Yonhap

Samsung Biologics Co., Ltd. (207940) and its labor union agreed to hold more talks, Yonhap reported Tuesday. The dispute covers wages and changes to personnel systems.

The parties will continue bargaining before a second mediation session on September 15. Their earlier discussions had not resolved the issues submitted for mediation. Yonhap reported the new meeting plan after the first mediation stage.

The report did not announce a settlement or a strike date. The next stated procedural step is the second mediation meeting on September 15. The company's market capitalisation was ₩66.7 trillion at Tuesday's close.

Sources

  1. Yonhap
Written from the filing or the Korean-language report it cites, not translated from it. Figures against this company's own statements are computed from DART data on kstock. kstock does not issue buy, sell or hold ratings and this is not investment advice.

One Korean filing a day, in English.

kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.

Free. Unsubscribe anytime. Sent by Substack · Privacy